Herman Waldmann

Herman Waldmann FRS FMedSci (born 27 February 1945) is a British immunologist known for his work on therapeutic monoclonal antibodies. As of 2013, he is Emeritus Professor of Pathology at the Sir William Dunn School of Pathology at the University of Oxford.

Career and research

Waldmann worked in the Department of Pathology of the University of Cambridge from 1973, becoming head of the Immunology Division in 1989. In 1994, he took up the position of head of the Sir William Dunn School of Pathology at the University of Oxford.[1] He is a fellow of Lincoln College.[2]

Waldmann's research has focused on immunological tolerance and the harnessing of tolerance mechanisms to treat autoimmune diseases and enable transplant acceptance. He is best known for his work on therapeutic monoclonal antibodies and their use to achieve tolerance, particularly Campath-1, now licensed as Lemtrada for the treatment of Multiple Sclerosis.

Awards and honours

Waldmann was elected a Fellow of the Royal Society in 1990.[3] He delivered the 1992 Bradshaw Lecture at the Royal College of Physicians.[4] In 1998, he was a founding fellow of the Academy of Medical Sciences.[5] In 2008, he was awarded an honorary doctorate ScD(Hon) by the University of Cambridge.[6] In 2010 he became a Fellow of the Royal College of Physicians (FRCP)

References

  1. ↑ Sir William Dunn School of Pathology: History (accessed 6 January 2009)
  2. ↑ Lincoln College, University of Oxford: Professor Herman Waldmann: Professor of Pathology (accessed 23 March 2010)
  3. ↑ Royal Society: Lists of Royal Society Fellows 1660–2007, accessed 1 May 2011
  4. ↑ "Herman Waldmann". Cranfield University. Retrieved 2011-08-25.
  5. ↑ Academy of Medical Sciences: Fellows: Professor Herman Waldmann (accessed 23 March 2010)
  6. ↑ University of Cambridge: 2008 Overview: Honorary degrees (accessed 23 March 2010)

External links